chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Coming home.  I did not recognize a street  I was on. It was on a street that I always drive on. My husband, was driving. He had the shot 15 minutes before me. Same lot.  He was really more out of it. We had brain fog for about 4 hours. We rested.
Severe chills and uncomfortably cold hands and feet from 9:00 p.m. evening of injection (11/20/2020) through about 4:00 a.m. 11/21/2020. Followed by severe headache through now (11/23/2020), currently almost 11:00 a.m.  Ketorolac 10 mg plus Sumatriptan 25 mg has finally given me some relief.
Stabbing chest pains on the upper left side.  Hurt a lot and went on and on
On 1/10/01, came down with fever and pox. On 1/16/00, came to hospital ER with dehydration. On 1/17/01, was admitted until 1/19/01. Dx'd with pneumonia, lethargic, cellulitis and lack of coordination.
Hives, facial swelling, nausea, ears red and painful, throat pain.  No difficulty breathing or swallowing.  Occurred within 15 minutes after receiving vaccines.
sl less than 24 hours had 100.4 temperature and jerking shivering type action  wher he was uncomfortabe and hit himself in the face   he is able to  drink formula and has no vomiting or diarrhea He continues these jerky not seizure like movemts through today 5//14 but they are decreasung
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (headache). On 29-Jan-2021, HEADACHE (headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.  No concomitant drugs and treatment drugs are provided     Reporter did not allow further contact
pt recv vax 7APR99 in the PM & father states that by 9APR99 pt had 104 fever;they gave APAP;10APR99 was lethargic, would jerk when awakened, would cry out uncontrollably in sleep, would laugh inappropriately;h/a, viral illness;
Nov. 7th inj. site swollen down to elbow, painful, hot, red, raised. Fever 100 x 3 days, felt bad, ached all over and had a headache. Saw PCP 11-9-12 told bad infection noted injection site had a darker red core in it, no drainage, but scabbed over. Her skin peeled where she had the injection. She received 3 courses of erythromycin 333mg tid. On 11/12/12 injection site about 50 cent piece size, not painful, not hot, not swollen.
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination.     No Medical History information was reported.    In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided  The vaccine was administered on 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022. The vial was initially stored in the refrigerator on 14Jan2022.  No treatment medication was provided
very sick from both vaccines; This case was reported by a consumer and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of illness (received 1st dose on an unknown date, refer case US2021AMR202716).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine, the patient experienced sickness. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received dose of Shingles vaccine and felt very sick and it did not last long 24 hours and so far, the patient had no shingles. The patient stated that it had been a year since he/she got it. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR202716:same reporter same patient
3-4 weeks after vaccines given, patient with swelling of thigh and not moving it.  He was otherwise acting well, no fever, no erythema, eating well, no tenderness.  Plain film showed periosteal elevation.  MRI showed muscle abscess.  Patient admitted for IV antibiotics.  Diagnosed with MSSA left quadricep abscess and left femur osteomyelitis.
This spontaneous case reported by a consumer, describes the occurrence of arthralgia (sore arm) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history provided. On Jan 5, 2021, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; unspecified dose. On an unknown date, patient experienced arthralgia (sore arm). At the time of the report, arthralgia (sore arm) outcome: unknown.
Day 1-within 4 lt. shoulder joint with "itchiness,tingling sensation on the left side from elbow through shoulder, back of neck down through trap /shoulder blade into serratous area of ribcage (treated with Tylenol, Aleve and Benadryl) Day 2- 24 hours later left joints, shoulder, elbow, hand progressively worse, one incident of tachycardia, Itching continued and progressed to left side of face, (treated with Tylenol, Aleve and Benadryl) Day 3- 48 hours later more significant bil. joint soreness in knees, hands/thumbs, shoulders, elbows- itchiness/tingling sensation continued on left side (treated with Tylenol, Aleve and Benadryl) Day 4- joint pain continues  as well as itching/tingling (treated with Tylenol, Aleve and Benadryl)
Left abdominal pain, spleen; Myalgia; Fever 103; Fatigue; Sore throat; This is a spontaneous report from a contactable other healthcare professional (patient). A 50-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in right arm on 18Mar2021 at 14:45 (at the age of 50 years old) as a single dose for COVID-19 immunisation. Medical history included psoriasis and immune compromised (1/2 spleen). Concomitant medications included zolpidem tartrate (AMBIEN), venlafaxine hydrochloride (EFFEXOR), and imipramine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW6200) via an unspecified route of administration in right arm on 13Feb2021 at 12:00 PM, at the age of 50, as a single dose for COVID-19 immunisation. The patient also previously took niacin on unspecified date and experienced drug allergy. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient had not received any other vaccines within 4 weeks prior vaccination. On 18Mar2021 at 18:45 (night of vaccination and the next day), the patient experienced myalgia, fever 103, fatigue and sore throat. On 19Mar2021 (2nd night), the patient experienced left abdominal pain, spleen, still continues. The adverse events resulted into emergency room/department or urgent care visit. Therapeutic measures were taken for the events myalgia, fever 103, fatigue, sore throat and left abdominal pain which included unspecified treatment and test. The clinical outcome of the event myalgia, fever 103, fatigue, sore throat and left abdominal pain, spleen was not resolved at the time of this report.   Information about lot/batch number cannot be obtained. No further information expected.  Amendment: This follow-up report is being submitted to amend previously reported information: date of laboratory test (body temperature) was added as 18Mar2021; event onset of abdominal pain was updated as 19Mar2021; and corresponding data field was ticked to reflect that all adverse events resulted into emergency room visit.
Patient is a 62 y.o. male with PMH of a-fib, CAD s/p CABG, mechanical aortic and mitral valve replacements on warfarin, renal transplant x2 (most recently '18), DM1, pancreatic transplant, adrenal insufficiency, OSA on CPAP and remote hx of DVT who presents in transfer from hospital where he has been admitted with covid since 1/17. His symptoms started on 1/14 per outside H&P with chest congestion, rhinorrhea and cough. He originally presented there on 1/17 due to dehydration from <24h of vomiting. At that time was mildly hypoxic requiring 2L O2 NC.  He was treated with IVF, 2 days of remdesivir and dexamethasone. There was a question of UTI so he received ceftriaxone x3 days, but UCx grew mixed flora an it was stopped. BCx were negative.     He had been doing well enough that they were considering discharge on home O2, but then during the last 24 hours his respiratory failure worsened to the point of requiring high flow oxygen, and then bipap was started last night due to increased WOB. He received tocilizumab yesterday. Attempts were made to transfer to the transplant center, but they were full with a waiting list. Therefore, he was transferred here while awaiting bed. Of note, his creatinine has been stable throughout the stay at hospital and his INRs have been therapeutic and supratherapeutic. Because of that, CTA for PE was felt to be low yield. He did receive stress dose steroids for a period of time after he had increased abdominal symptoms. At this time he is on 6mg dex bid at direction of transplant center. His other immunosuppressants are being held.   Upon arrival here, he states he feels fatigued and has a minimally productive cough, but otherwise feels ok. Denies chest pain, presyncope, orthopnea, leg swelling, abdominal pain, current n/v. We attempted to wean him off Bipap to HF mask 100% 70L and he desaturated to 85%, so we put him back on CPAP of 10, at 80% FiO2 with O2 sat of 96%.
Less than recommended dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete dose administered in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number 25ZH4, expiry date 27-OCT-2024) for prophylaxis.   On 21-AUG-2023, the patient received the 4th dose of Kinrix. On 21-AUG-2023, an unknown time after receiving Kinrix, the patient experienced incomplete dose administered (Verbatim: Less than recommended dose).  The outcome of the incomplete dose administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date 21 August 2023 A healthcare professional reported that a dose of Kinrix was given but as the liquid was being administered, it leaked from the syringe. The provider did not wish to place a product quality complaint. Information about event, vaccine and patient was provided. The vaccine administration Facility was the same as primary reporter. A healthcare professional reported that a dose of Kinrix was given but as the liquid was being administered, it leaked from the syringe which led to incomplete dose administered.  The reporter consented to follow up
10 hrs - + rash - in morning, raised rash over entire body - No other complaints - no fever, H/A
PATIENT GOT THE SHOT AND FELL AFTER 5 MINUTES WITHIN THE PHARMACY, UPON ASKING HE SAID THAT HE IS SCARED OF GETTING SHOTS THAT IS WHY HE FELL, WE OFFERED HIM PARAMEDICAL SERVICES, AND HE DENIED. PT WAS GIVEN AND SOME SNACKS, HE WAS DOING PERFECTLY FINE, LEFT THE PHARMACY AFTER 15 MINUTES MORE WAITING INSIDE THE PHARMACY.
On a Thursday night, 12/1, I started having a very extreme sore throat, difficult to swallow and sleep. Friday morning It felt better but Friday night it was extreme again. On Saturday I tried to do some chores but I was very tired, I had to take a nap that afternoon. On Sunday I tried to get treatment, I got an appt at the pharmacy clinic, appt for Monday morning. They gave me a COVID-19 test which came back positive. They sent me home, and I isolated. I was taking ADVIL to help me sleep over the weekend, the clinic didn't prescribe anything because of the time line. By Wednesday I was feeling better, wasn't falling asleep. Thursday I felt okay, good enough to go out to a scheduled event but stayed home to isolate. I think I was good at that point, overall it was very mild besides the extreme sore throat the first few days.
Patient received the pediatric dose of Hep A (Havrix). Patient was informed and was given the adult dose.
cough; swelling from the injection site on his left arm through his hand; Initial information received on 09-Mar-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 5 years old male patient who had cough and swelling from the injection site on his left arm through his hand while receiving vaccine diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccine [Quadracel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 23-Feb-2022, the patient received a  dose of suspect Quadracel dosage: 0.5 ml, formulation: injection, (strength: unknown) expiration date: 23-Feb-2024, lot: C5970AA via intramuscular route in the left arm for prophylactic vaccination.  On 24-Feb-2022 the patient developed a non-serious event "cough", "swelling from the injection site on his left arm through his hand" (vaccination site swelling) (latency: same day).   No lab data was reported.  Action taken with Quadracel was not applicable.  It was not reported if the patient received a corrective treatment for the events.  At the time of reporting, the outcome was Recovered / Resolved on an unknown date for the event swelling from the injection site on his left arm through his hand and was Recovered / Resolved on 09-Mar-2022 for the event cough.
restless leg; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age (age: 71; unit: unknown) started to received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient developed a restless leg on unspecified date. The patient elevated it on some pillows and it subsided within a few hours. The outcome of the event was recovering.  No follow-up attempts are possible. No further information is expected. Information regarding Lot/Batch No. cannot be obtained.
The patient had a sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (The patient had a sore arm) in an elderly female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 050o22A) for COVID-19 prophylaxis.     Concurrent medical conditions included Migraine. Concomitant products included RIMEGEPANT SULFATE (NURTEC ODT) for Migraine, BUDESONIDE and PANTOPRAZOLE SODIUM SESQUIHYDRATE (PANTOPRAZOLE [PANTOPRAZOLE SODIUM SESQUIHYDRATE]) for an unknown indication.    On 11-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (The patient had a sore arm). At the time of the report, PAIN IN EXTREMITY (The patient had a sore arm) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not reported.  The patient does not remember which arm she received the vaccine.   This case was linked to MOD-2023-747030, MOD-2023-746962 (Patient Link).
Received #2 dose of HPV4 (Gardasil) and approximately 10 minutes after receiving the vaccine she started feeling dizzy.  She was seen in the office 8-2-11 with persistant dizziness and complaints of fatigue.  No vomiting, but is nauseated.  She feels like her "world is spinning."  No changes with position, the dizziness is constant.  Has been afebrile. These symptoms have persisted since vaccination.  LMP:  7-18-2011.  Orthostatic BP at 8-2-11 office visit:  Supine  134/80; sitting  124/77; standing  119/79.  Was prescribed Meclizine 25mg, 1-2 tabs BID-TID prn dizziness.  CBC W/ diff, CMP, Thyroid screen, CAT scan of brain all WNL. BMI:  39.68.  Birth control: Depo Provera.
This case was received from a health professional on 28 June 2007.  A five-year-old male patient with a medical history of amblyopia experienced red welts on the left arm after receiving an intramuscular left arm injection of DAPTACEL (lot number C2606AA) and intramuscular left arm injection of IPOL (lot number Z0326) on 20 June 2007.  A subcutaneous right arm injection of VARIVAX (Merck, lot number 0536U) was also administered on 20 June 2007.  On 22 June 2007, two days after administration, the patient developed a 16 to 18 cm area of red welts on the left arm at the site of the injection.  He was seen by his physician, and it was unknown if the events had recovered.  Follow-up information received on 25 July 2007 from the patient's treating physician.  The treating physician provided a diagnosis of cellulitis and a revised latency date of 21 June 2007 relating to the onset of left arm redness which measured 16-18cm at the site of injection.  Follow-up information verified the patient had recovered.  Follow up information received on 23 August 2007 from the patient's treating physician.  The patient had not received any antibiotic therapy for this event and the cellulitis had resolved on 27 June 2007.  The reporter clarified that VARIVAX had been administered intramuscularly in the patient's right arm.  No additional information had been reported.
8-21-13 4 A febrile seizures focal (L) eye deviation.
Caller stated she asked the children this morning if they had any side effects and the reply was a little sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 6 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 30Dec2021 (Lot number: FK5127, Expiration Date: 30Apr2022) at the age of 6 years as dose 1 (tris), single for covid-19 immunisation. Relevant medical history included: "Autoimmune" (unspecified if ongoing). There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 30Dec2021, outcome "unknown", described as "Caller stated she asked the children this morning if they had any side effects and the reply was a little sore arm".  Additional information: Reporter stated the vial had the date of manufacture of Aug2021 instead of an expiration date. Reporter stated she asked the pharmacist what the expiration date was and the pharmacist showed her the print out of the 9 month expiration. Printed Manufacturing Date: 09 Month Expiry Date: Aug2021=30Apr2022. Patient did not have any history of all previous immunization with the Pfizer vaccine and not received any additional vaccines administered on same date of the Pfizer suspect. Family medical history relevant to adverse event was not reported. Relevant tests were none reported.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101885369 same product and event, different patient
On 8 May 07 I received my second anthrax shot. On 11 May 07 around 2000. The area where I received the shots started to turn blue and began to itch. Everyday after 11 May 07 the itch got worst. On 18 May 07 a rash appeared. and everyday after that the rash spreaded, and the itch got worst.
This spontaneous report as received from a healthcare worker refers to a 14 year old patient of an unknown gender. On an unknown date, the patient was vaccinated with a dose of PROQUAD (Merck) (dose, route, lot # and expiration date were not provided) which was considered an inappropriate schedule of vaccine administered. No adverse effect reported. Additional information has been requested.
Headaches, coughing, pressure behind eyes, fever above 100 degrees, chills, fatigue
Diarrhea, rapid heart rate, tremors, anxiety, sweating, intolerance to warm weather. diagnosis of hyperthyroidism.
Vaccine administration error related to temperature excursion from recommended storage temperature, not known to this writer to be associated with an adverse event. The clinic has relayed to this writer that prior to the vaccine's thawing and administration to the vaccine recipient, the administered vaccine was stored in frozen temperatures for longer than recommended by the manufacturer. This VAERS writer assigned to form completion was not the administrator of this vaccine.
Patient noticed rash Sunday night (5/28/17) around 8pm - she came in to pharmacy and showed pharmacist who said rashes have been reported and instructed patient to contact MD if it worsened - this was on Mon 5/29 - patient called back on Tues (5/30) evening to let pharmacist know rash was much larger (despite taking BENADRYL), itchy, warm, and larger. Visited clinic at work where instructed compress and more BENADRYL. Patient also C/O headache.
Information has been received from a Registered Nurse (R.N.) concerning around an 18 year old female who was vaccinated with a dose of Gardasil. The patient fainted after receiving the Gardasil. Unspecified medical attention was sought by the patient, the patient recovered. The reporter reported that two other patient experienced fainting after receiving the dose of Gardasil. Additional information has been requested.
SYMPTOMS: Soreness at injection site (left deltoid) progressing to intense burning pain, loss of ROM of motion in left shoulder; spasms, burning sensations, constriction sensations, tingling, numbness in left arm and hand. DIAGNOSIS: RSD/CRPS (no known cure). TREATMENT: Nerve Block, PT, medications to help relieve symptoms.
5/10/08 local reaction 7 x 5 cm erythema/induration.  Treated with cool compresses/BENADRYL/observation - follow up visit on 5/11/08 for report of worsening redness.  No fever, no systemic reaction.  Mild increase in erythema but induration is improved.  Prescribed Keflex for 10 days as a precautionary for cellulitis.
This was my second COVID vaccine. During the first vaccine, I felt no pain during injection. During this injection, I felt a very sharp pain. The injector told me that she felt my muscle spasm as she put the needle in. Within one hour, my arm got very sore to the point where I couldn't move it. I am now 6 days later and still have extreme pain in my left arm and have a hard time sleeping due to the discomfort.